Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
  • Big Wins
  • About Us
  • Featured Priorities
  • National Vaccine Advisory Committee
  • Vaccines National Strategic Plan
Breadcrumb
  1. HHS
  2. Vaccines and Immunizations
  3. U.S. National Vaccine Plan
  4. Annual Report 2013
  5. Goal 4: Ensure a Stable Supply of, Access to, and Better Use
  • National Vaccine Plan (NVP)
    • Goal 1: Develop New and Improved Vaccines
    • Goal 2: Enhance the Vaccine Safety System
    • Goal 3: Support Communications to Enhance Informed Vaccine Decision Making
    • Goal 4: Ensure a Stable Supply of, Access to, & Better Use of Recommended Vaccines in the United States
    • Goal 5: Increase Global Prevention of Death & Disease through Safe & Effective Vaccination

Goal 4: Ensure a Stable Supply of, Access to, and Better Use of Recommended Vaccines in the United States

Healthy People 2020 data show that in 2011 the majority of childhood and toddler vaccination coverage rates met or exceeded their Healthy People 2020 targets. Substantial disparities exist among racial and ethnic groups in adult and adolescent vaccination levels for many vaccines. And, for many vaccines targeted to adolescents and adults such as the HPV vaccine, current coverage levels are falling short of targets.  

Goal 4 focuses on addressing barriers to reaching goals for vaccine coverage.  The intent of Goal 4 is clear: make sure people of all ages in the United States have access to a readily available supply of recommended vaccines, and to develop effective strategies to increase their use.  To achieve this, the implementation of the National Vaccine Plan focuses on several areas, including ensuring a consistent and adequate supply of vaccines, adequate delivery of vaccines to patients by health care providers, reducing financial barriers to vaccination, educating health care providers in vaccination counseling, and conducting surveillance of vaccine coverage, vaccine effectiveness, and the occurrence of vaccine-preventable diseases as well as diseases that may one day be prevented by vaccines that are not yet available.  The U.S. Department of Health and Human Services (HHS) and its partner agencies are working hard to manage these challenges.  One of the primary responsibilities of the National Vaccine Program Office is fostering collaboration across HHS agencies as a way to efficiently and effectively manage these challenges.

Selected highlights:

  • Contracts awarded, through the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority, to five vaccine manufacturers to produce master seed stocks for influenza viruses with pandemic potential.
  • Established an International Society for Pharmaceutical Engineering award-winning cell-based influenza vaccine manufacturing facility in the United States to increase the domestic supply seasonal and pandemic influenza vaccines.
  • Partnerships with non-government organizations to make influenza vaccination more financially accessible.
  • Accurate tracking of vaccine-preventable diseases and disease rates, including supporting specialized systems (e.g., those for pertussis tracking).
  • New mapping tool to track influenza vaccination claims rates by Medicare beneficiaries.
  • Identifying health care system and provider barriers and facilitators of immunization.
  • Expanding access to vaccines via partnerships with pharmacists and other immunization providers.
  • Broadening of access to vaccines without cost-sharing through the Affordable Care Act.
  • Working to foster use of health information technology for vaccine and immunization tracking.

Read more in the full State of the National Vaccine Plan 2013 Annual Report


Dr. Anne Schuchat, Director of the National Center for Immunization and Respiratory Diseases, comments on the urgent need for healthcare providers to recommend the HPV vaccine to their adolescent patients in order to achieve adequate coverage and prevent cancer.

Dr. Joshua Sharfstein, Secretary of the Maryland Department of Health and Mental Hygiene, and colleagues David Blythe and Laura Herrera comment on the role of pharmacists in maintaining and increasing immunization coverage.

Dr. LJ Tan, Chief Strategy Officer of the Immunization Action Coalition, comments on the need for continued support for our national immunization infrastructure.

 

Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed March 28, 2016
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy